Given a paragraph and a claim, classify it this way: If the claim contradicts the evidence present in the paragraph, classify the claim as '0'. If the claim has multiple supporting *AND* contradicting evidences, classify the claim as '1'. If the claim has supporting evidence and the paragraph is in overall favor of the claim, then classify the claim as '2'.

Paragraph: The release does not include any cost information. The summary gives anabsolute risk reduction percentage of 0.27% for patients who received radiation compared to those who did not. It also includes the number needed to treat (370) to save one patient. This is good detail, but we would also have liked more context on the controversies of DCIS treatment. A HealthNewsReview.org podcast provides a deeper look here. The release briefly discusses harms. The release says patients who received radiation and lumpectomy had more "local" recurrences of the cancer, but their overall survival was modestly better than patients who did not have radiation (a 0.27% reduction over 15 years). The release should have given some mention to the harms of radiation treatment, particularly since the potential benefit of radiotherapy was very small. The release provides details on the association study, which reviewed records from thousands of patients. The release also includes limitations of the study. There is no disease mongering. The release provides context on the prevalence of DCIS in the U.S. The style of this news release was to punt the question of funders and "conflicts" into a web link where the reader has to chase it down. It would better serve readers to have funders and any conflicts of interest spelled out in the release. Here is what the release states: Editor's Note:The article contains conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc. The study notes that researchers received funding from Canadian government agencies. The release let readers down in providing the broader context about controversies over appropriate treatment if any for women diagnosed with DCIS. It's common knowledge that radiation and surgery are widely available treatments. There was no claim of novelty. The release stated that results are based on an association study of a national database containing more than 140,000 patient records. It's unclear if similar studies have been completed. We found no unjustifiable language. Claim: Association of radiation therapy plus lumpectomy in reduced risk of dying in women with DCIS
1